Table 4.

Objective response and disease control rate in HER2-null and HER2-low patients

	Total			HR-positive			HR negative
	HER2-null	HER2-low	p-value	HER2-null	HER2-low	p-value	HER2-null	HER2-low	p-value
Eriburin, n (%)
ORR	8 (22.9)	4 (9.1)	0.09	8 (32.0)	4 (10.5)	0.03	0 (0)	0 (0)	NA
DCR	23 (65.7)	25 (56.8)	0.42	19 (76.0)	22 (57.9)	0.14	4 (40.0)	3 (50.0)	1.0
Capecitabine, n (%)
ORR	11 (26.8)	5 (15.2)	0.23	9 (27.3)	5 (16.1)	0.28	2 (25.0)	0 (0)	1.0
DCR	31 (75.6)	29 (87.9)	0.18	27 (81.8)	27 (87.1)	0.73	4 (50.0)	2 (100)	0.47

HER 2 Human epidermal growth factor receptor 2, HR hormone receptor, ORR overall response rate, DCR disease control rate